Cervical cancer
Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.
Where to go
1 hospital in India taking patients for this trial.
Registry summary (technical)
Systemic chemotherapy with or without palliative radiation represents the current standard of care in patients with recurrent or metastatic cervix cancer. In addition, pelvic radiotherapy including brachytherapy is also recommended. There is no consensus on the treatment of metastatic site in patients with oligo-metastatic or oligo-recurrent cervix cancer. Also, it is not clear if addition of local treatment to systemic chemotherapy benefits all patients with metastatic disease or a select few with limited systemic disease burden. It's presently unclear which patients derive maximum benefit wi…
Sponsor: Tata Memorial Hospital
NCT07400809 on ClinicalTrials.gov
Last updated on the registry 17 Feb 2026 · read by us 20 Oct 2026